Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Direct-to-Consumer, Randomized, Double-blind, Placebo-controlled Study With Open-label Extension Investigating the Effects of Mimio Biomimetic Cell Care on Metabolic Health in Healthy Overweight Individuals in a Home Setting

NCT06790407 is registered in ClinicalTrials.gov with Mimio Health, Inc. as lead sponsor.

NCT NCT06790407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06790407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Direct-to-Consumer, Randomized, Double-blind, Placebo-controlled Study With Open-label Extension Investigating the Effects of Mimio Biomimetic Cell Care on Metabolic Health in Healthy Overweight Individuals in a Home Setting
Lead sponsor
Mimio Health, Inc.
Phase
Observational
Overall status
Completed
Start date
August 26, 2024
Completion date
January 31, 2025
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy